Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.845
-0.105 (-3.56%)
Aug 12, 2026, 2:51 PM EDT - Market open
Editas Medicine Employees
Editas Medicine had 87 employees as of December 31, 2025. The number of employees decreased by 159 or -64.63% compared to the previous year.
Employees
87
Change (1Y)
-159
Growth (1Y)
-64.63%
Revenue / Employee
$540,287
Profits / Employee
-$849,989
Market Cap
436.94M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 87 | -159 | -64.63% |
| Dec 31, 2024 | 246 | -19 | -7.17% |
| Dec 31, 2023 | 265 | 39 | 17.26% |
| Dec 31, 2022 | 226 | -38 | -14.39% |
| Dec 31, 2021 | 264 | 29 | 12.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 179 |
| Cabaletta Bio | 158 |
| Ocugen | 116 |
| Scribe Therapeutics | 89 |
| Larimar Therapeutics | 71 |
| Prothena Corporation | 67 |
| Eupraxia Pharmaceuticals | 49 |
| Fennec Pharmaceuticals | 35 |
EDIT News
- 6 days ago - Editas Medicine reports Q2 EPS (15c), consensus (28c) - TheFly
- 6 days ago - Editas Medicine Announces Second Quarter 2026 Results and Business Updates - GlobeNewsWire
- 6 days ago - Editas Medicine Earnings release: Q2 2026 - Filings
- 6 days ago - Editas Medicine Quarterly report: Q2 2026 - Filings
- 7 days ago - Editas Medicine Strengthens Board of Directors with Appointment of Patrick T. Ellinor, M.D. - GlobeNewsWire
- 2 months ago - The Healthcare M&A Wave - Forbes
- 2 months ago - Editas Medicine Transcript: AGM 2026 - Transcripts
- 2 months ago - Editas Medicine Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts